41 related articles for article (PubMed ID: 24684700)
1. Signal regulatory protein beta 2 is a novel positive regulator of innate anticancer immunity.
Visser N; Nelemans LC; He Y; Lourens HJ; Corrales MG; Huls G; Wiersma VR; Schuringa JJ; Bremer E
Front Immunol; 2023; 14():1287256. PubMed ID: 38116002
[TBL] [Abstract][Full Text] [Related]
2. Molecular Pathways: Activating T Cells after Cancer Cell Phagocytosis from Blockade of CD47 "Don't Eat Me" Signals.
McCracken MN; Cha AC; Weissman IL
Clin Cancer Res; 2015 Aug; 21(16):3597-601. PubMed ID: 26116271
[TBL] [Abstract][Full Text] [Related]
3. Cell rigidity and shape override CD47's "self"-signaling in phagocytosis by hyperactivating myosin-II.
Sosale NG; Rouhiparkouhi T; Bradshaw AM; Dimova R; Lipowsky R; Discher DE
Blood; 2015 Jan; 125(3):542-52. PubMed ID: 25411427
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism in the innate immune receptor SIRPα controls CD47 binding and autoimmunity in the nonobese diabetic mouse.
Wong AS; Mortin-Toth S; Sung M; Canty AJ; Gulban O; Greaves DR; Danska JS
J Immunol; 2014 Nov; 193(10):4833-44. PubMed ID: 25305319
[TBL] [Abstract][Full Text] [Related]
5. Registered report: the CD47-signal regulated protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors.
Chroscinski D; Maherali N; Griner E;
Elife; 2015 Jan; 4():. PubMed ID: 25621565
[TBL] [Abstract][Full Text] [Related]
6. Macrophages eat cancer cells using their own calreticulin as a guide: roles of TLR and Btk.
Feng M; Chen JY; Weissman-Tsukamoto R; Volkmer JP; Ho PY; McKenna KM; Cheshier S; Zhang M; Guo N; Gip P; Mitra SS; Weissman IL
Proc Natl Acad Sci U S A; 2015 Feb; 112(7):2145-50. PubMed ID: 25646432
[TBL] [Abstract][Full Text] [Related]
7. CD47 Enhances In Vivo Functionality of Artificial Antigen-Presenting Cells.
Bruns H; Bessell C; Varela JC; Haupt C; Fang J; Pasemann S; Mackensen A; Oelke M; Schneck JP; Schütz C
Clin Cancer Res; 2015 May; 21(9):2075-83. PubMed ID: 25593301
[TBL] [Abstract][Full Text] [Related]
8. RRx-001 Acts as a Dual Small Molecule Checkpoint Inhibitor by Downregulating CD47 on Cancer Cells and SIRP-α on Monocytes/Macrophages.
Cabrales P
Transl Oncol; 2019 Apr; 12(4):626-632. PubMed ID: 30738349
[TBL] [Abstract][Full Text] [Related]
9. SIRPα-CD47 Immune Checkpoint Blockade in Anticancer Therapy.
Veillette A; Chen J
Trends Immunol; 2018 Mar; 39(3):173-184. PubMed ID: 29336991
[TBL] [Abstract][Full Text] [Related]
10. Multinucleated Giant Cells: Current Insights in Phenotype, Biological Activities, and Mechanism of Formation.
Ahmadzadeh K; Vanoppen M; Rose CD; Matthys P; Wouters CH
Front Cell Dev Biol; 2022; 10():873226. PubMed ID: 35478968
[TBL] [Abstract][Full Text] [Related]
11. Targeting the CD47-SIRPα signaling axis: current studies on B-cell lymphoma immunotherapy.
Zhang J; Jin S; Guo X; Qian W
J Int Med Res; 2018 Nov; 46(11):4418-4426. PubMed ID: 30226089
[TBL] [Abstract][Full Text] [Related]
12. Selenium nanoparticles induce suppressed function of tumor associated macrophages and inhibit Dalton's lymphoma proliferation.
Gautam PK; Kumar S; Tomar MS; Singh RK; Acharya A; Kumar S; Ram B
Biochem Biophys Rep; 2017 Dec; 12():172-184. PubMed ID: 29090279
[TBL] [Abstract][Full Text] [Related]
13. SIRP Alpha Protein Downregulates in Human Astrocytoma: Presumptive Involvement of Hsa-miR-520d-5p and Hsa-miR-520d-3p.
Deshpande RP; Chandra Sekhar YBVK; Panigrahi M; Babu PP
Mol Neurobiol; 2017 Dec; 54(10):8162-8169. PubMed ID: 27900675
[TBL] [Abstract][Full Text] [Related]
14. Signal regulatory protein α associated with the progression of oral leukoplakia and oral squamous cell carcinoma regulates phenotype switch of macrophages.
Ye X; Zhang J; Lu R; Zhou G
Oncotarget; 2016 Dec; 7(49):81305-81321. PubMed ID: 27793032
[TBL] [Abstract][Full Text] [Related]
15. Interplay between Cellular and Molecular Inflammatory Mediators in Lung Cancer.
Orozco-Morales M; Soca-Chafre G; Barrios-Bernal P; Hernández-Pedro N; Arrieta O
Mediators Inflamm; 2016; 2016():3494608. PubMed ID: 26941482
[TBL] [Abstract][Full Text] [Related]
16. Suppressed expression of homotypic multinucleation, extracellular domains of CD172α (SIRP-α) and CD47 (IAP) receptors in TAMs upregulated by Hsp70-peptide complex in Dalton's lymphoma.
Gautam PK; Acharya A
Scand J Immunol; 2014 Jul; 80(1):22-35. PubMed ID: 24684700
[TBL] [Abstract][Full Text] [Related]
17. Antigenic Hsp70-peptide upregulate altered cell surface MHC class I expression in TAMs and increases anti-tumor function in Dalton's lymphoma bearing mice.
Gautam PK; Acharya A
Tumour Biol; 2015 Mar; 36(3):2023-32. PubMed ID: 25431260
[TBL] [Abstract][Full Text] [Related]
18. Soluble extracellular domains of human SIRPα and CD47 expressed in Escherichia coli enhances the phagocytosis of leukemia cells by macrophages in vitro.
Lin Y; Yan XQ; Yang F; Yang XW; Jiang X; Zhao XC; Zhu BK; Liu L; Qin HY; Liang YM; Han H
Protein Expr Purif; 2012 Sep; 85(1):109-16. PubMed ID: 22813925
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
